Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ ZENODOarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article
Data sources: ZENODO
addClaim

DIABETIC ANGIOPATHY AND MECHANISMS OF ISCHEMIC HEART DISEASE DEVELOPMENT IN TYPE 2 DIABETES MELLITUS

Authors: Jo'rayeva, Gulhayo Jalol kizi;

DIABETIC ANGIOPATHY AND MECHANISMS OF ISCHEMIC HEART DISEASE DEVELOPMENT IN TYPE 2 DIABETES MELLITUS

Abstract

Type 2 diabetes mellitus (T2DM) is one of the most common chronic metabolic disorders associated with severe cardiovascular complications. Among these complications, diabetic angiopathy and ischemic heart disease (IHD) occupy a leading position in morbidity and mortality worldwide. Chronic hyperglycemia contributes to vascular endothelial damage, oxidative stress, inflammation, and accelerated atherosclerosis, all of which play critical roles in the pathogenesis of coronary artery disease. Diabetic angiopathy affects both microvascular and macrovascular circulation, leading to impaired myocardial perfusion and increased risk of ischemic events. This article discusses the major pathogenic mechanisms linking diabetic angiopathy with the development of ischemic heart disease in patients with type 2 diabetes mellitus. Understanding these mechanisms is essential for early diagnosis, prevention, and effective therapeutic strategies aimed at reducing cardiovascular complications in diabetic patients.

Powered by OpenAIRE graph
Found an issue? Give us feedback